Search

everythinglearnresearchcommunity

for

Search:↓

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Ritlecitinib works well and is safe for treating alopecia areata.

Dupilumab may help treat alopecia areata, but more research is needed.

A 10-year-old boy recovered from a scalp infection caused by a fungus after treatment with itraconazole.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Semaglutide may help some skin disorders but can also cause skin issues.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Dupilumab can cause unexpected scalp issues, so early symptom recognition is important to avoid hair loss.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Baricitinib successfully treated severe hair loss.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.